Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Kite Pharma
Biotech
J&J, Bayer, Santa Ana, Regenxbio and more—Chutes & Ladders
J&J exec to retire after 17 years. Bayer’s top biotech leader departs. Former Kite exec takes the reins of new biotech.
Gabrielle Masson
,
Andrea Park
,
Fraiser Kansteiner
Jun 14, 2024 8:30am
Ex-Kite leader helms Santa Ana’s ship with $168M in hand
Jun 13, 2024 8:00am
How to get cell therapies flying off-the-shelf
May 31, 2024 9:00am
Cell therapy reckoning: An unmet need remains in oncology
May 30, 2024 10:00am
A biotech reckoning: 'We've lost our luster in cell therapies'
May 29, 2024 10:22am
Gilead hands Arcellx $285M to expand BCMA cell therapy deal
Nov 15, 2023 10:00am